TheraPHIX™, vivoPHIX™, genoPHIX™ and virusPHIX™

RNAssist Blog

Choose a category:NewsCase StudiesEventsResearchAll posts
Events · 23 September 2025RNAssist at the RNA Vaccines and Therapeutics Conference 2025

Our CEO, Andrew Goldsborough, will be attending the RNA Vaccines and Therapeutics Conference in London on 23–24 September 2025. Hosted by CPI at the Royal College of Physicians,...

EventsRead More ›Events · 10 June 2025We're attending the UK Clinical Vaccine Network Conference 2025

Are you ready to leave freezer logistics behind? Thursday 12 June at the UK Clinical Vaccine Network Conference, our CEO, Dr Andrew Goldsborough, will unveil TheraPHIX™—an ambie...

EventsRead More ›Events · 24 October 2024RNAssist is attending the World Vaccine Congress

Join us at the World Vaccine Congress next week as we showcase our latest breakthrough in mRNA-LNP stability, TheraPHIX™!We’re thrilled that our CEO, Andrew Goldsborough will be...

EventsRead More ›Events · 20 July 2023RNAssist sponsors the 23rd Genomic Standards Consortium Meeting

We are delighted to announce that we are sponsoring The Genomic Standards Consortium (GSC)’s 23rd meeting. The meeting will be held in Bangkok, Thailand, from August 7th to 11th...

EventsRead More ›Events · 23 January 2023We’re attending the mRNA – Based Therapeutics Summit

We are delighted to attend the 2nd Annual mRNA-Based Therapeutics Summit 24th-26th January 2023 in Berlin. Following the successful development of vaccines against Covid-19, bio...

EventsRead More ›